[HTML][HTML] Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment

X Wu, J Wang, Q Liang, R Tong, J Huang… - Biomedicine & …, 2022 - Elsevier
Focal adhesion kinase (FAK, also known as PTK2) is a tyrosine kinase that regulates
integrin and growth factor signaling pathways and is involved in the migration, proliferation …

[HTML][HTML] HDAC2 as a target for develo** anti-cancer drugs

H Jo, K Shim, HU Kim, HS Jung, D Jeoung - Computational and Structural …, 2023 - Elsevier
Histone deacetylases (HDACs) deacetylate histones H3 and H4. An imbalance between
histone acetylation and deacetylation can lead to various diseases. HDAC2 is present in the …

HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B

M Wang, J Liao, J Wang, M Xu, Y Cheng, L Wei… - Cell Death & …, 2024 - nature.com
Hepatocellular carcinoma (HCC) is a significant global health challenge. The activation of
autophagy plays an essential role in promoting the proliferation and survival of cancer cells …

[HTML][HTML] Functions and mechanisms of microRNA-31 in human cancers

T Yu, P Ma, D Wu, Y Shu, W Gao - Biomedicine & Pharmacotherapy, 2018 - Elsevier
MicroRNAs can exhibit opposite functions in different tumors. MiR-31 is a representative
example as it can not only enhance tumor development and progression in pancreatic …

Histone deacetylase 2 selective inhibitors: a versatile therapeutic strategy as next generation drug target in cancer therapy

MG Shetty, P Pai, RE Deaver, K Satyamoorthy… - Pharmacological …, 2021 - Elsevier
Acetylation and deacetylation of histone and several non-histone proteins are the two
important processes amongst the different modes of epigenetic modulation that are involved …

MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma

HJ Bae, JH Noh, JK Kim, JW Eun, KH Jung, MG Kim… - Oncogene, 2014 - nature.com
Abstract Mammalian sirtuin 1 (SIRT1) has connected to an ever widening circle of activities
that encompass cellular stress resistance, energy metabolism and tumorigenesis. However …

MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer

HS Kim, KS Lee, HJ Bae, JW Eun, Q Shen… - …, 2015 - pmc.ncbi.nlm.nih.gov
MicroRNA-31 (miR-31) is among the most frequently altered microRNAs in human cancers
and altered expression of miR-31 has been detected in a large variety of tumor types, but the …

[HTML][HTML] PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to …

K Bishayee, AR Khuda-Bukhsh, SO Huh - Molecules and cells, 2015 - Elsevier
Controlled release of medications remains the most convenient way to deliver drugs. In this
study, we precipitated gold nanoparticles with quercetin. We loaded gold-quercetin into poly …

Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective

DI Tsilimigras, I Ntanasis-Stathopoulos, D Moris… - Surgical oncology, 2018 - Elsevier
Hepatocellular carcinoma (HCC) is a major contributor to the global cancer burden. Given
the current limited options to treat advanced HCC, understanding the molecular basis of …

HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer

HJ **e, JH Noh, JK Kim, KH Jung, JW Eun, HJ Bae… - PloS one, 2012 - journals.plos.org
Histone deacetylases (HDACs) are known to play a central role in the regulation of several
cellular properties interlinked with the development and progression of cancer. Recently …